Minerva Neurosciences, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $-31.5M | $-31.0M | $-27.1M | $-56.9M | $-3.3M |
| Depreciation & Amortization | $11.1K | $16.5K | $17.3K | $33.9K | — |
| Depreciation | — | — | — | — | — |
| Amortization | — | — | — | — | — |
| Stock-Based Compensation | $5.0M | $3.6M | $2.2M | $18.0M | $655.7K |
| Net Cash from Operating Activities | $3.1M | $-25.7M | $-24.3M | $-36.0M | $-2.2M |
| Investing Activities | |||||
| Capital Expenditures | $52.4K | — | — | $45.6K | $3.2K |
| Business Acquisitions | — | — | — | — | — |
| Net Cash from Investing Activities | $-107.2M | — | — | — | — |
| Financing Activities | |||||
| Dividends Paid | — | — | — | — | — |
| Stock Repurchases | $389 | — | — | — | — |
| Net Cash from Financing Activities | $47.2M | — | — | — | — |
| Net Change in Cash | $-56.9M | — | — | — | — |
| Free Cash Flow | $3.0M | — | — | $-36.0M | $-2.2M |